首页> 外文期刊>Qatar Medical Journal >Antibiotic Resistance Pattern Among Aerobic Gram Negative Bacilli Isolated from Patients in Intensive Care Units
【24h】

Antibiotic Resistance Pattern Among Aerobic Gram Negative Bacilli Isolated from Patients in Intensive Care Units

机译:重症监护病房患者需氧革兰阴性杆菌中的抗生素耐药性模式

获取原文
           

摘要

To study the antimicrobial resistance pattern of aerobic Gram-negative bacilli isolated from patients in intensive care units in Hamad Medical Corporation, 108 non-duplicate isolates from 60 patients with nosocomial infections were determined by Vitek machine. The minimal inhibitory concentration of 14 antimicrobials was determined by E-test and results were interpreted according to the National Committee for Clinical Laboratory Standards guidelines. The most common species was Pseudomonas aeruginosa High levels of resistance were seen to second and third generation cephalosporins, piperacillin, fi-lactam Ji-lactamase inhibitors combinations, and gentamicin. The most active agents were amikacin, meropenem and imipenem (resistance 19%, 19%, 20% respectively). We conclude that second and third generation cephalosporins, piperacillin, fi-lactam/fi-lactamase inhibitors combinations and gentamicin are not suitable drugs for empirical monotherapy for aerobic Gram-negative infections in intensive care units in Qatar.
机译:为了研究哈马德医学公司重症监护病房患者中分离出的好氧革兰氏阴性细菌的耐药性模式,采用Vitek机器对60例医院感染患者中的108株非重复菌株进行了鉴定。通过E检验确定了14种抗菌剂的最低抑菌浓度,并根据美国国家临床实验室标准委员会指南对结果进行了解释。最常见的物种是铜绿假单胞菌。对第二代和第三代头孢菌素,哌拉西林,β-内酰胺类β-内酰胺酶抑制剂和庆大霉素的耐药性较高。活性最高的药物是丁胺卡那霉素,美洛培南和亚胺培南(耐药率分别为19%,19%,20%)。我们得出的结论是,第二代和第三代头孢菌素,哌拉西林,fi-内酰胺/ fi-内酰胺酶抑制剂组合和庆大霉素都不适合在卡塔尔重症监护病房进行有氧革兰氏阴性感染的经验性单药治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号